BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36518240)

  • 1. Combination of transsphenoidal endoscopic surgery and presurgical somatostatin analogs in thyrotropin (TSH)-secreting pituitary adenomas: Treatment outcome and long-term remission at a single pituitary center.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Front Endocrinol (Lausanne); 2022; 13():1061029. PubMed ID: 36518240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)-secreting pituitary adenomas.
    Liu J; Yang Y; Duan L; Chai X; Zhu H; Deng K; Lian X; Yao Y
    Clin Endocrinol (Oxf); 2023 Sep; 99(3):306-314. PubMed ID: 37144621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate postoperative measurement of thyroid-stimulating hormone as an early predictor of remission in thyroid-stimulating hormone-secreting pituitary adenomas.
    Kim SH; Ku CR; Na M; Yoo J; Kim W; Jung IH; Kim KW; Moon JH; Kim D; Lee EJ; Kim SH; Kim EH
    J Neurosurg; 2020 Mar; 134(3):794-800. PubMed ID: 32168476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test.
    Han R; Shen L; Zhang J; Xie J; Fang W; Sun Q; Bian L; Zhou Y; Wang S; Ning G; Wang W; Ye L
    Thyroid; 2020 Sep; 30(9):1236-1244. PubMed ID: 32212919
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
    Gatto F; Grasso LF; Nazzari E; Cuny T; Anania P; Di Somma C; Colao A; Zona G; Weryha G; Pivonello R; Ferone D
    Pituitary; 2015 Oct; 18(5):583-91. PubMed ID: 25326851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation.
    Malchiodi E; Profka E; Ferrante E; Sala E; Verrua E; Campi I; Lania AG; Arosio M; Locatelli M; Mortini P; Losa M; Motti E; Beck-Peccoz P; Spada A; Mantovani G
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2069-76. PubMed ID: 24552222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
    De Herdt C; Philipse E; De Block C
    Eur J Endocrinol; 2021 Jul; 185(2):R65-R74. PubMed ID: 34132199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience.
    Macchia E; Gasperi M; Lombardi M; Morselli L; Pinchera A; Acerbi G; Rossi G; Martino E
    J Endocrinol Invest; 2009 Oct; 32(9):773-9. PubMed ID: 19636221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Endoscopic Endonasal Transsphenoidal Approach for Thyrotropin-Secreting Pituitary Adenomas: Single-Center Experience and Clinical Outcomes of 49 Patients.
    Sen HE; Ceylan EC; Atayev S; Sozen M; Bayrak BY; Cetinarslan B; Anik Y; Icli AD; Cabuk B; Anik I; Ceylan S
    World Neurosurg; 2022 Nov; 167():e1275-e1283. PubMed ID: 36096394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment and outcome of TSH-producing pituitary adenomas.
    Rotermund R; Riedel N; Burkhardt T; Matschke J; Schmidt NO; Aberle J; Flitsch J
    Acta Neurochir (Wien); 2017 Jul; 159(7):1219-1226. PubMed ID: 28204898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Outcome and Treatment of Thyrotropin-Secreting Pituitary Tumors in a Tertiary Referral Center.
    Herguido NG; Fuentes ED; Venegas-Moreno E; Maorad LB; Flores-Martinez A; Ruiz PR; Dueñas MC; Roldán F; Fajardo E; Ruiz-Valdepeñas EC; Kaen A; Martín Schrader I; Cano DA; Soto-Moreno A
    World Neurosurg; 2019 Oct; 130():e634-e639. PubMed ID: 31276853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of preoperative short-term octreotide treatment to surgery in thyrotropin-secreting pituitary adenomas: a retrospective cohort study.
    Zhao R; Fan K; Wan W
    BMC Endocr Disord; 2023 Aug; 23(1):176. PubMed ID: 37587420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma).
    Yu B; Zhang Z; Song H; Chi Y; Shi C; Xu M
    Med Sci Monit; 2017 Apr; 23():1947-1955. PubMed ID: 28434012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reference center study in thyrotropin-secreting pituitary adenomas: clinicopathological, therapeutic and long-term follow-up outcomes.
    Sözen M; Bayrak BY; Selek A; Şen HE; Çetinarslan B; Cantürk Z; Civriz AH; Balcı S; Gezer E; Köksalan D; Ceylan S
    Endocrine; 2023 Dec; 82(3):622-630. PubMed ID: 37561380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma.
    Sanno N; Teramoto A; Osamura RY
    J Neurosurg; 2000 Aug; 93(2):194-200. PubMed ID: 10930003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The surgery of thyrotropin-secreting pituitary adenomas and the significance of thyroid stimulating hormone level in follow-up].
    Yang YY; Liu H; Hu A; Zou Y; Xing B; Yao Y; Wang RZ; Lian W
    Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(47):3825-3828. PubMed ID: 28057099
    [No Abstract]   [Full Text] [Related]  

  • 19. Long term treatment of a thyrotropin-secreting microadenoma with somatostatin analogues.
    Prieto-Tenreiro A; Díaz-Guardiola P
    Arq Bras Endocrinol Metabol; 2010; 54(5):502-6. PubMed ID: 20694413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide.
    Kuhn JM; Arlot S; Lefebvre H; Caron P; Cortet-Rudelli C; Archambaud F; Chanson P; Tabarin A; Goth MI; Blumberg J; Catus F; Ispas S; Beck-Peccoz P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1487-91. PubMed ID: 10770186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.